Status:
COMPLETED
Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)
Collaborating Sponsors:
Office of Dietary Supplements (ODS)
Conditions:
Insulin Resistance
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine the effectiveness of the nutritional supplement chromium picolinate in improving insulin resistance, a symptom of diabetes, in HIV-infected patients. The ulti...
Detailed Description
Insulin resistance occurs when blood glucose levels get too high for the body to respond. Certain anti-HIV drugs are associated with increased insulin resistance and may lead to abnormal fat distribut...
Eligibility Criteria
Inclusion
- HIV infected
- Currently taking an anti-HIV drug regimen
- Insulin Resistant:fasting glucose between 5.56 and 7mmol/L and/or two hour post-glucose load between 7.78 and 11.11mmol/L
Exclusion
- Cancer
- Acute illness that would interfere with the study
- Hypogonadism
- Hypothyroidism
- Untreated hypertension
- CD4 count less than 300 cells/mm3
- Viral load greater than 35,000 copies/ml
- Untreated hepatitis C virus infection
- Pregnancy
- Diabetes
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT00109746
Start Date
November 1 2005
End Date
June 1 2010
Last Update
March 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
State University of New York/General Clinical Research Center
Stony Brook, New York, United States, 11794